MedTrace Pharma A/S: Financial statements 2017
CVR: 36497661
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
MedTrace Pharma A/S (CVR 36497661) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -2,166,821 and a net result of DKK -2,002,540 compared with DKK 1,157,243 the year before. Equity in the 2017 report amounted to DKK 2,441,174. The solvency ratio was 16%. The company had 5 employees in the financial year.
- Gross Profit
- DKK -2,166,821
- Profit/Loss
- DKK -2,002,540
- Equity
- DKK 2,441,174
- Total Assets
- DKK 15,268,621
- Employees
- 5
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | -2.2 mio. | -2 mio. | 2.4 mio. | 5 |
| 2016 | - | 1.5 mio. | 1.2 mio. | 4.2 mio. | 4 |
| 2015 | - | -232.4 mio. | -245.5 mio. | 2.8 mia. | - |
Official annual report
Keep an eye on MedTrace Pharma A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
MedTrace Pharma A/S has published its annual report for 2016. Gross profit came to DKK 1,519,441, and the net result was DKK 1,157,243.
As of April 20, 2017, Ulrik Spork has joined the board of directors of MedTrace Pharma A/S.
As of April 20, 2017, Bjarne Henning Jensen has left the board of directors of MedTrace Pharma A/S.
About MedTrace Pharma A/S
MedTrace Pharma A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2015. The company is registered under the industry Udlejning og leasing af andet materiel, udstyr og andre materielle aktiver til events. The company was previously named MedTrace A/S and Medtrace ApS. The management consists of Peter Juul Kristensen and Lykke Jul Rømer. The board consists of Erik Anders Strömqvist (chair), Cesare Orlandi, Charlotte Vindfeldt and Claus Henrik Berner Møller. The company's owners include Arbejdsmarkedets Tillægspension, MedTravest IV ApS and Swisscanto Private Equity I KmGK. The company has 32 employees (2026). In 2025, the company reported revenue of DKK 1,759,371 and a net result of DKK -35,131,112 compared with DKK -15,355,876 the year before. Equity in the 2025 report amounted to DKK 302,613,643.